BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6324311)

  • 1. Role of neutralising antibody in passive immunity to bluetongue infection.
    Jeggo MH; Wardley RC; Taylor WP
    Res Vet Sci; 1984 Jan; 36(1):81-6. PubMed ID: 6324311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial inoculation of sheep with two bluetongue virus types.
    Jeggo MH; Wardley RC; Brownlie J; Corteyn AH
    Res Vet Sci; 1986 May; 40(3):386-92. PubMed ID: 3016851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune response of sheep to bluetongue virus.
    Ghalib HW; Cherrington JM; Adkison MA; Osburn BI
    Prog Clin Biol Res; 1985; 178():489-96. PubMed ID: 2989890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine.
    Oura CA; Wood JL; Floyd T; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Simmons H; Batten CA
    Vaccine; 2010 Mar; 28(15):2749-53. PubMed ID: 20123052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and serological response of sheep to serial challenge with different bluetongue virus types.
    Jeggo MH; Gumm ID; Taylor WP
    Res Vet Sci; 1983 Mar; 34(2):205-11. PubMed ID: 6304836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental bluetongue infections in gnotobiotic lambs and kids.
    Livingston CW; McConnell S; Cummings G; Gauer BB
    Am J Vet Res; 1983 Jan; 44(1):129-31. PubMed ID: 6297338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and serological outcome following the simultaneous inoculation of three bluetongue virus types into sheep.
    Jeggo MH; Wardley RC; Taylor WP
    Res Vet Sci; 1984 Nov; 37(3):368-70. PubMed ID: 6097969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques.
    Jeggo MH; Wardley RC; Brownlie J
    Immunology; 1984 Jul; 52(3):403-10. PubMed ID: 6086501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic response of sheep to inactivated and virulent bluetongue virus.
    Stott JL; Barber TL; Osburn BI
    Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency and efficacy of inactivated bluetongue virus vaccines.
    Stevens DR; Stott J; Osburn BI; Giles R; Wiesehahn GP; Barber TL
    Prog Clin Biol Res; 1985; 178():649-52. PubMed ID: 2989914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactogenic immunity and milk antibody isotypes to transmissible gastroenteritis virus in sows exposed to porcine respiratory coronavirus during pregnancy.
    Lanza I; Shoup DI; Saif LJ
    Am J Vet Res; 1995 Jun; 56(6):739-48. PubMed ID: 7653882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of recombinant DNA technology for the development of a bluetongue virus subunit vaccine.
    Huismans H
    Onderstepoort J Vet Res; 1985 Sep; 52(3):149-51. PubMed ID: 3003649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
    Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
    Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature and duration of protective immunity to bluetongue virus infection.
    Roy P
    Dev Biol (Basel); 2003; 114():169-83. PubMed ID: 14677687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies and bluetongue virus diagnosis.
    Anderson J
    Prog Clin Biol Res; 1985; 178():497-504. PubMed ID: 2989891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of ovine cytotoxic T cells in protection against bluetongue virus infection.
    Jeggo MH; Wardley RC; Brownlie J
    Prog Clin Biol Res; 1985; 178():477-87. PubMed ID: 2989889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
    Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
    Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence of bluetongue virus for British sheep.
    Jeggo MJ; Corteyn AH; Taylor WP; Davidson WL; Gorman BM
    Res Vet Sci; 1987 Jan; 42(1):24-8. PubMed ID: 3029846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.